Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation

Jordan C. Barone, Annie Ho, Lauren M. Osborne, Tory A. Eisenlohr-Moul, A. Leslie Morrow, Jennifer L. Payne, C. Neill Epperson, Liisa Hantsoo

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Psychology

Veterinary Science and Veterinary Medicine